In the context of MM, Xie’s team engineered MM exosomes to, respectively, upregulate the expression of IL-2, interferon-γ (IFN-g), and TNF-α, by the genetic manipulation of MM cells [131]. This evidence concerns the gene IL2 and Miyoshi myopathy.